Skip to content

The role of Sestrin2 in evaluating severity and prognosis of sepsis

The role of Sestrin2 in evaluating severity and prognosis of sepsis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038228
Enrollment
Unknown
Registered
2020-09-14
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Normal control group:Nil

Sponsors

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of the sepsis group: 1. Diagnosis of sepsis; 2. Aged between 18-65 years old, regardless of gender; 3. Hospitalization time> 24 hours; 4. The patients volunteered to participate in the clinical study and signed the informed consent. Inclusion criteria of healthy volunteers: 30 healthy volunteers who had physical examination in our hospital during the same period were taken as control.

Exclusion criteria

Exclusion criteria: 1. Dying condition (estimated survival time < 24 hours); 2. Previous history of diabetes; 3. Previous malignant tumor; 4. Previous neurodegenerative disease (Parkinson's disease); 5. Pregnant patients; 6. Participants in other clinical trials within 1 months.

Design outcomes

Primary

MeasureTime frame
Blood sestrin2;

Secondary

MeasureTime frame
SOFA scores;GCS scores;APACHEII scores;high-sensitivity C-reactive protein;Procalcitonin;Lactic Acid;Blood Glucose;High-Sensitivity Cardiac Troponin;NT-proBNP;White Blood Cell Count;Hemoglobin;Hematocrit;Platelet Count;Alanine Aminotransferase;Aspartate Aminotransferase;Total Bilirubin;Direct Bilirubin;Indirect Bilirubin;Lactate Dehydrogenase;Urea Nitrogen;Creatinine;Arterial blood PH;Oxygen Partial Pressure;partial pressure of carbon dioxide;bicarbonate ion-;D-dimer;International normalized ratio;Fibrinogen;28-day survival;Ventilator use days;ICU hospital stay;Total days in hospital;

Countries

China

Contacts

Public Contactwei zhu

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology

tjjzkzw512@163.com+86 13971209138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026